VELA Investment Management LLC Sells 22,370 Shares of Bruker Corporation $BRKR

VELA Investment Management LLC reduced its holdings in Bruker Corporation (NASDAQ:BRKR) by 23.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,924 shares of the medical research company’s stock after selling 22,370 shares during the quarter. VELA Investment Management LLC’s holdings in Bruker were worth $4,509,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Los Angeles Capital Management LLC bought a new position in Bruker in the 4th quarter valued at $26,000. Allworth Financial LP raised its holdings in shares of Bruker by 40.6% in the third quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock valued at $29,000 after buying an additional 257 shares during the last quarter. Essential Partners LLC acquired a new position in Bruker during the 1st quarter worth about $36,000. Global Retirement Partners LLC acquired a new position in Bruker during the 2nd quarter worth about $38,000. Finally, Parallel Advisors LLC grew its holdings in Bruker by 121.0% during the 4th quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock worth $41,000 after acquiring an additional 479 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on BRKR. Citigroup lowered their price objective on shares of Bruker from $60.00 to $53.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Zacks Research lowered Bruker from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 2nd. Guggenheim lifted their price target on shares of Bruker from $50.00 to $70.00 and gave the stock a “buy” rating in a research report on Monday, June 29th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Bruker in a report on Monday, August 31st. Finally, Barclays upped their target price on shares of Bruker from $53.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Bruker has an average rating of “Hold” and an average price target of $56.64.

Bruker Stock Performance

Shares of BRKR stock opened at $58.50 on Tuesday. The firm has a 50 day moving average price of $58.73 and a two-hundred day moving average price of $48.87. The company has a market capitalization of $8.91 billion, a PE ratio of -83.57, a price-to-earnings-growth ratio of 1.79 and a beta of 1.26. Bruker Corporation has a 12-month low of $29.84 and a 12-month high of $65.30. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The company had revenue of $838.50 million during the quarter, compared to analysts’ expectations of $853.57 million. During the same quarter in the previous year, the business posted $0.32 earnings per share. Bruker’s quarterly revenue was up 5.2% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, analysts predict that Bruker Corporation will post 2.12 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Bruker’s payout ratio is currently -28.57%.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.